159 related articles for article (PubMed ID: 22920639)
1. Monoclonal gammopathy of undetermined significance: an update for nephrologists.
Parry HM; Pratt G; Hutchison CA
Adv Chronic Kidney Dis; 2012 Sep; 19(5):291-6. PubMed ID: 22920639
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice. Monoclonal gammopathy of undetermined significance.
Bladé J
N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
[No Abstract] [Full Text] [Related]
3. Light-chain MGUS: implications for clinical practice.
van Rhee F
Lancet; 2010 May; 375(9727):1670-1. PubMed ID: 20472153
[No Abstract] [Full Text] [Related]
4. [Spectrum of monoclonal gammopathies].
Matuszkiewicz-Rowińska J; Wieliczko M
Wiad Lek; 2017; 70(6 pt 2):1170-1174. PubMed ID: 29533907
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
Graziani MS; Merlini G
Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
[TBL] [Abstract][Full Text] [Related]
7. Involved/uninvolved immunoglobulin ratio identifies monoclonal gammopathy of undetermined significance patients at high risk of progression to multiple myeloma.
Espiño M; Medina S; Blanchard MJ; Villar LM
Br J Haematol; 2014 Mar; 164(5):752-5. PubMed ID: 24261626
[No Abstract] [Full Text] [Related]
8. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
9. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Willrich MAV; Murray DL; Kyle RA
Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
[TBL] [Abstract][Full Text] [Related]
11. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
13. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
[TBL] [Abstract][Full Text] [Related]
14. Free light-chains and renal disorders: when small is worse.
Hutchison CA; Pratt G
Lancet; 2010 Oct; 376(9748):1220; author reply 1221-2. PubMed ID: 20934588
[No Abstract] [Full Text] [Related]
15. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
Bird J; Behrens J; Westin J; Turesson I; Drayson M; Beetham R; D'Sa S; Soutar R; Waage A; Gulbrandsen N; Gregersen H; Low E;
Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
[No Abstract] [Full Text] [Related]
16. Monoclonal gammopathy of renal significance with light-chain deposition disease diagnosed postrenal transplant: a diagnostic and therapeutic challenge.
Nambirajan A; Bhowmik D; Singh G; Agarwal SK; Dinda AK
Transpl Int; 2015 Mar; 28(3):375-9. PubMed ID: 25441103
[TBL] [Abstract][Full Text] [Related]
17. [MGRS - monoclonal gammopathy of renal significance].
Wieliczko M; Matuszkiewicz-Rowińska J
Wiad Lek; 2017; 70(6 pt 2):1175-1178. PubMed ID: 29533908
[TBL] [Abstract][Full Text] [Related]
18. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
Honkanen E; Pettersson T; Teppo AM
Clin Nephrol; 1995 Jul; 44(1):22-7. PubMed ID: 7554529
[TBL] [Abstract][Full Text] [Related]
19. [Benign monoclonal gammopathies].
Sibilia J; Fermand JP
Rev Prat; 1993 Feb; 43(3):289-92. PubMed ID: 8502957
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]